The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Gynecologic Cancer Case Studies

Krishnansu S. Tewari, MD, FACOG, FACS: Options That May Prolong Survival

Krishnansu S. Tewari, MD, FACOG, FACS
Published Online:Jun 16, 2015
Sarah W. is a 62-year-old Caucasian woman who works as a travel agent.

Gynecologic Cancers: Case 1

Gynecologic Cancers: Case 1
Gynecologic Cancers: Case 2
<iframe width="560" height="315" src="https://www.youtube.com/embed/Ga_G8-oLW8w" frameborder="0" allowfullscreen></iframe>
Krishnansu S. Tewari, MD, FACOG, FACS says that in relation to options available for controlling Sarah's recurrent metastatic disease, all of these options may improve PFS. A significant impact on OS, however, is unlikely and has not been shown previously in clinical trials for recurrent disease.
##
Publications
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.